BridgeMD
New treatment option for Embryo Transfer
Official title Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes
ClinicalTrials.gov ID: NCT07499817
What this study is testing
What is pentoxifylline 400 mg?
pentoxifylline 400 mg is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for embryo transfer.
Also referred to as Trental ® Sanofi co..
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this work was to investigate the effect of different vasodilators as pentoxifylline in women with unexplained infertility using IVF
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 43, women only
You may be able to join if
- as good quality day five frozen embryos.
You likely can't join if
- history of endocrine diseases,
- history of any previous surgery that couldm compromise the integrity of endometrium,
- cardiovascular, renal and liver diseases,
The study team makes the final eligibility decision.
Where it's taking place
- Banī Suwayf, Beni Suweif Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 43 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banī Suwayf, Beni Suweif Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.